drugset / Trial / NCT07686679

A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

NCT07686679

Phase 4 Not yet recruiting 300 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia

Timeline

Start
2026-07
Primary completion
2027-10
Completion
2027-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator DA-9701-R Unknown
Subject LUCORIDALINES Unknown

Indications